A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

To improve labeling, the team conceived of a way—the conceptual essence of CuRVE—to resolve the speed mismatch. The strategy was to continuously control the pace of antibody binding while at ...

To improve labeling, the team conceived of a way -- the conceptual essence of CuRVE -- to resolve the speed mismatch. The strategy was to continuously control the pace of antibody binding while at ...

In their new study in Nature Biotechnology, they also demonstrate that the ability to label proteins with antibodies at the single-cell level across whole brains can reveal insights left hidden by ...

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D tissues with unprecedented speed, uniformity, and versatility. Using the ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody ...

Zoetis (ZTS) announced that it has updated the U.S. label for Librela, following its submission of a supplement to the FDA. This supplement ...

The Institute for Protein Innovation (IPI), a nonprofit research institute dedicated to advancing protein science, today announced that it received a $500,000 grant from the Chan Zuckerberg Initiative ...